| Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis X Zhang, L Peng, Y Luo, S Zhang, Y Pu, Y Chen, W Guo, J Yao, M Shao, ... Nature communications 12 (1), 5291, 2021 | 193 | 2021 |
| A body map of somatic mutagenesis in morphologically normal human tissues R Li, L Di, J Li, W Fan, Y Liu, W Guo, W Liu, L Liu, Q Li, L Chen, Y Chen, ... Nature 597 (7876), 398-403, 2021 | 157 | 2021 |
| Single-cell transcriptomic analysis in a mouse model deciphers cell transition states in the multistep development of esophageal cancer J Yao, Q Cui, W Fan, Y Ma, Y Chen, T Liu, X Zhang, Y Xi, C Wang, L Peng, ... Nature communications 11 (1), 3715, 2020 | 108 | 2020 |
| Epithelial cells activate fibroblasts to promote esophageal cancer development Y Chen, S Zhu, T Liu, S Zhang, J Lu, W Fan, L Lin, T Xiang, J Yang, ... Cancer Cell 41 (5), 903-918. e8, 2023 | 79 | 2023 |
| Advancing CAR T cell therapy through the use of multidimensional omics data J Yang, Y Chen, Y Jing, MR Green, L Han Nature Reviews Clinical Oncology 20 (4), 211-228, 2023 | 66 | 2023 |
| Expanding PROTACtable genome universe of E3 ligases Y Liu, J Yang, T Wang, M Luo, Y Chen, C Chen, Z Ronai, Y Zhou, ... Nature Communications 14 (1), 6509, 2023 | 62 | 2023 |
| Multi-omic characterization of genome-wide abnormal DNA methylation reveals diagnostic and prognostic markers for esophageal squamous-cell carcinoma Y Xi, Y Lin, W Guo, X Wang, H Zhao, C Miao, W Liu, Y Liu, T Liu, Y Luo, ... Signal Transduction and Targeted Therapy 7 (1), 53, 2022 | 44 | 2022 |
| Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma J Chu, X Niu, J Chang, M Shao, L Peng, Y Xi, A Lin, C Wang, Q Cui, Y Luo, ... Theranostics 10 (8), 3488, 2020 | 37 | 2020 |
| CCGD-ESCC: a comprehensive database for genetic variants associated with esophageal squamous cell carcinoma in Chinese population L Peng, S Cheng, Y Lin, Q Cui, Y Luo, J Chu, M Shao, W Fan, Y Chen, ... Genomics, Proteomics and Bioinformatics 16 (4), 262-268, 2018 | 20 | 2018 |
| Computational identification of preneoplastic cells displaying high stemness and risk of cancer progression T Liu, X Zhao, Y Lin, Q Luo, S Zhang, Y Xi, Y Chen, L Lin, W Fan, J Yang, ... Cancer Research 82 (14), 2520-2537, 2022 | 18 | 2022 |
| CstF64-Induced Shortening of the BID 3′UTR Promotes Esophageal Squamous Cell Carcinoma Progression by Disrupting ceRNA Cross-talk with ZFP36L2 A Lin, P Ji, X Niu, X Zhao, Y Chen, W Liu, Y Liu, W Fan, Y Sun, C Miao, ... Cancer Research 81 (22), 5638-5651, 2021 | 18 | 2021 |
| Bioinformatics: Advancing biomedical discovery and innovation in the era of big data and artificial intelligence Y Liu, Y Chen, L Han The Innovation Medicine 1 (1), 100012, 2023 | 14 | 2023 |
| A multi‐omics perspective of CAR T cell therapy J Yang, Y Chen, L Han Clinical and Translational Medicine 13 (5), e1274, 2023 | 7 | 2023 |
| Spatial landscape of the tumor immune microenvironment Y Chen, Y Liu, L Han Trends in Cancer 9 (6), 459-460, 2023 | 3 | 2023 |
| PancanQTLv2. 0: a comprehensive resource for expression quantitative trait loci across human cancers C Chen, Y Liu, M Luo, J Yang, Y Chen, R Wang, J Zhou, Y Zang, L Diao, ... Nucleic acids research 52 (D1), D1400-D1406, 2024 | 2 | 2024 |
| Dynamic immune signatures as biomarkers for irAEs J Yang, Y Chen, L Han Trends in Cancer 9 (5), 379-380, 2023 | 1 | 2023 |
| Ancestral Differences in Anticancer Treatment Efficacy and Their Underlying Genomic and Molecular Alterations M Luo, J Yang, AA Schäffer, C Chen, Y Liu, Y Chen, C Lin, L Diao, Y Zang, ... Cancer Discovery, OF1-OF19, 2025 | | 2025 |
| The pharmacogenomic and immune landscape of snoRNAs in human cancers R Wang, C Chen, Y Liu, M Luo, J Yang, Y Chen, L Ma, L Yang, C Lin, ... Cancer Letters 605, 217304, 2024 | | 2024 |
Dongxin LinCancer Institute & Hospital, Chinese Academy of Medical Sciences確認したメール アドレス: cicams.ac.cn